Abingdon Health Plc (LON:ABDX – Get Free Report) shares dropped 0.3% during mid-day trading on Thursday . The company traded as low as GBX 10 ($0.13) and last traded at GBX 10.22 ($0.13). Approximately 39,218 shares changed hands during trading, a decline of 86% from the average daily volume of 272,277 shares. The stock had previously closed at GBX 10.25 ($0.13).
Abingdon Health Stock Performance
The company has a debt-to-equity ratio of 55.57, a quick ratio of 1.96 and a current ratio of 1.79. The business’s fifty day simple moving average is GBX 10.65 and its 200-day simple moving average is GBX 9.65. The firm has a market capitalization of £12.95 million, a PE ratio of -1,022.00 and a beta of 0.09.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Read More
- Five stocks we like better than Abingdon Health
- How to invest in blue chip stocks
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- What is the Hang Seng index?
- Progress Software Stock Back in the Green After Beating Forecasts
- How to Calculate Return on Investment (ROI)
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.